+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

India In Vitro Fertilization Services Market: India Opportunity Analysis and Industry Forecast, 2018-2026

  • ID: 4989473
  • Report
  • October 2019
  • Region: India
  • 127 Pages
  • Allied Analytics LLP

FEATURED COMPANIES

  • Bloom Fertility Cente
  • Bourn Hall Clinic
  • Lab IVF Asia Pte. Ltd.
  • LG Life Sciences
  • Nova IVI Fertility
The India IVF services market was valued at $478.2 million in 2018 and is estimated to reach $1,453.0 million by 2026, registering a CAGR of 14.7% during the analysis period.




In vitro fertilization (IVF) is a type of assisted reproductive technology. In this technique the ovum is artificially fertilized in laboratory settings and then implanted into the uterus. IVF is one of the widely used treatments, which is used for the assistance of couples with infertility problems, single mothers, and the LGBT community to procreate. The delayed pregnancy in women is one of the major driving factors of the IVF services market, as the chances of conceiving decrease with age. However, the success rate of IVF technique is higher in the age group of 35-39 years.

The India IVF services market is expected to witness significant growth during the forecast period owing to an increase in infertility rates caused due to rise in stress levels, changes in lifestyle, and a surge in incidence of fertility-related diseases. Low awareness toward this technique in the society restricts the market growth. Rising prevalence due to increasing risk factors, such as obesity, stress, polycystic ovarian syndrome (PCOS), sexually transmitted infections, endometrial tuberculosis, and other medical conditions, is expected to offer lucrative opportunities for the market growth during the forecast period.

The India IVF market is segmented based on gender, procedure, offering, cycle type, and end user. Based on gender, it is divided into female infertility, male infertility, and both (combined) infertility. Based on procedure, it is classified into intracytoplasmic sperm injection (ICSI-IVF), non-ICSI-IVF, and intrauterine insemination (IUI). The offering segment includes drugs, media & reagents, and services.

Based on cycle type, the market is categorized into fresh cycle (non-donor), thawed cycle (non-donor), and donor egg IVF cycle. Based on end user, it is segmented into fertility clinics, hospitals, surgical centers, and clinical research institutes.

The prominent companies, hospitals, surgical centers, fertility centers, and clinical research institutes profiled in this report include Sun Pharmaceuticals Industries Ltd., Lab IVF Asia Pte. Ltd., LG Life Sciences, Cadila Pharmaceuticals Ltd., Bourn Hall Clinic, Morpheus Life Sciences Pvt. Ltd., Southend Fertility and IVF Centre, Nova IVI Fertility, Bloom Fertility Center, Manipalankur Andrology and Reproductive Medicine, Cloudnine Hospitals, Gunasheela Hospital Mathrutva Fertility Centre (A Unit Of Max HealthCare Pvt. Ltd.) Milann, and Oasis Center (a unit of the entity Sadguru Healthcare Services Pvt. Ltd.)

KEY MARKET BENEFITS
  • The study provides an in-depth analysis of the India IVF services market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • The report presents a quantitative analysis of the market from 2018 to 2026 to enable stakeholders to capitalize on the prevailing market opportunities.
  • An extensive analysis of the market based on application assists to understand the trends in the industry.
  • The key market players along with their strategies are thoroughly analyzed to understand the competitive outlook of the industry.

KEY MARKET SEGMENTS

By Gender
  • Female
  • Male
  • other

By Procedure
  • ICSI-IVF
  • Non-ICSI IVF
  • IUI

By Cycle Type
  • Fresh IVF Cycles
  • Thawed IVF Cycles
  • Donor Egg IVF Cycles

By End User
  • Fertility Clinics
  • Hospitals
  • Surgical Centers
  • Clinical Research Institutes

By Offering
  • IVF Drugs
  • IVF Media & Reagents
  • IVF and IUI Services

LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • Gunasheela Hospital
  • Mathrutva Fertility Centre (unit of max healthcare Pvt. Ltd.)
  • MilannoThe Fertility Center
  • Oasis Centre
  • Sun Pharmaceutical Industries Ltd.
  • LabIVF Asia Pte. Ltd.
  • LG Life Sciences Ltd.
  • Cadila Pharmaceuticals Limited
  • Bourn Hall Clinic
  • Morpheus Life Sciences Pvt.
  • Southend Fertility and IVF Centre
  • Nova IVI Fertility
  • Nova IVI Fertility
  • Manipal fertility hospital
  • Cloudnine Hospitals
Frequently Asked Questions about the Indian IVF Services Market

What is the estimated value of the Indian IVF Services Market?

The Indian IVF Services Market was estimated to be valued at $478.2 million in 2018.

What is the growth rate of the Indian IVF Services Market?

The growth rate of the Indian IVF Services Market is 14.9%, with an estimated value of $1453.0 million by 2026.

What is the forecasted size of the Indian IVF Services Market?

The Indian IVF Services Market is estimated to be worth $1453.0 million by 2026.

Who are the key companies in the Indian IVF Services Market?

Key companies in the Indian IVF Services Market include Sun Pharmaceuticals Industries Ltd., Lab IVF Asia Pte. Ltd., LG Life Sciences, Cadila Pharmaceuticals Ltd., Bourn Hall Clinic, Morpheus Life Sciences Pvt. Ltd., Southend Fertility and IVF Centre and Bloom Fertility Cente.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bloom Fertility Cente
  • Bourn Hall Clinic
  • Lab IVF Asia Pte. Ltd.
  • LG Life Sciences
  • Nova IVI Fertility

Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models
Chapter 2: Executive Summary
2.1. Key Findings of The Study
Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Overview
3.3. Market Size And Forecast
3.4. Regulatory Issues, Legislations, And Authorities
3.5. Insurance Reimbursement Scenario
3.6. An Overview of Ivf Services Across Key Metro Cities In India
3.7. Qualitative Study On Rise In Ivf Services In India
3.8. India Ivf Market, By Patient Pool And Patient Conversion Rate
3.9. Indian Landscape On Key Ivf Centers
3.10. Key Impacting Factors
3.10.1. Drivers
3.10.1.1. Impact Analysis of Drivers
3.10.2. Restraints
3.10.2.1. Impact Analysis of Restraints
Chapter 4: India Ivf Services Market, By Gender
4.1. Overview
4.2. Market Size And Forecast
4.3. Female Infertility
4.3.1. Market Size And Forecast
4.4. Male Infertility
4.4.1. Market Size And Forecast
4.5. Both
4.5.1. Market Size And Forecast
Chapter 5: India Ivf And Iui Services Market, By Procedure
5.1. Overview
5.2. Market Size And Forecast
5.3. Icsi Ivf
5.3.1. Market Size And Forecast
5.4. Non-Icsi Ivf
5.4.1. Market Size And Forecast
5.5. Iui
5.5.1. Market Size And Forecast
Chapter 6: India Ivf Services Market, By Cycle Type
6.1. Overview
6.2. Market Size And Forecast
6.3. Fresh Ivf Cycles (Non-Donor)
6.4. Thawed Ivf Cycles
6.4.1. Market Size And Forecast
6.5. Donor Egg Ivf Cycles
6.5.1. Market Size And Forecast
Chapter 7: India Ivf Services Market, By End User
7.1. Overview
7.2. Market Size And Forecast
7.3. Fertility Clinics
7.3.1. Market Size And Forecast
7.4. Hospitals
7.4.1. Market Size And Forecast
7.5. Surgical Centers
7.5.1. Market Size And Forecast
7.6. Clinical Research Institutes
7.6.1. Market Size And Forecast
Chapter 8: India Ivf Market, By offering
8.1. Overview
8.2. Market Size And Forecast
8.3. Ivf Drugs
8.3.1. Market Size And Forecast
8.4. Ivf Media And Reagents
8.4.1. Market Size And Forecast
8.5. Ivf And Iui Services
8.5.1. Market Size And Forecast
Chapter 9: Company Profiles
9.1. Gunasheela Hospital
9.1.1. Company Overview
9.1.2. Company Snapshot
9.1.3. Operating Business Segments:
9.1.4. Product Portfolio
9.1.5. Key Strategic Moves And Developments
9.2. Mathrutva Fertility Centre (Unit of Max Healthcare Pvt. Ltd.)
9.2.1. Company Overview
9.2.2. Company Snapshot
9.2.3. Operating Business Segments:
9.2.4. Product Portfolio
9.3. Milann- The Fertility Center
9.3.1. Company Overview
9.3.2. Company Snapshot
9.3.3. Operating Business Segments:
9.3.4. Product Portfolio
9.3.5. Key Strategic Moves And Developments
9.4. Oasis Centre (Unit of The Entity Sadguru Healthcare Services Pvt. Ltd.)
9.4.1. Company Overview
9.4.2. Company Snapshot
9.4.3. Operating Business Segments
9.4.4. Product Portfolio
9.5. Sun Pharmaceutical Industries Ltd.
9.5.1. Company Overview
9.5.2. Company Snapshot
9.5.3. Operating Business Segments
9.5.4. Product Portfolio
9.5.5. Business Performance
9.6. Labivf Asia Pte. Ltd.
9.6.1. Company Overview
9.6.2. Company Snapshot
9.6.3. Operating Business Segments
9.6.4. Product Portfolio
9.7. Lg Life Sciences
9.7.1. Company Overview
9.7.2. Company Snapshot
9.7.3. Operating Business Segments
9.7.4. Product Portfolio
9.8. Cadila Pharmaceuticals Limited
9.8.1. Company Overview
9.8.2. Company Snapshot
9.8.3. Operating Business Segments
9.8.4. Product Portfolio
9.9. Bourn Hall Clinic
9.9.1. Company Overview
9.9.2. Company Snapshot
9.9.3. Product Portfolio
9.9.4. Key Strategic Moves And Developments
9.10. Morpheus Life Sciences Pvt. Ltd.
9.10.1. Company Overview
9.10.2. Company Snapshot
9.10.3. Product Portfolio
9.11. Southend Fertility And Ivf Centre
9.11.1. Company Overview
9.11.2. Company Snapshot
9.11.3. Product Portfolio
9.12. Nova Ivi Fertility
9.12.1. Company Overview
9.12.2. Company Snapshot
9.12.3. Product Portfolio
9.12.4. Key Strategic Moves And Developments
9.13. Bloom Fertility Center
9.13.1. Company Overview
9.13.2. Company Snapshot
9.13.3. Operating Business Segments
9.13.4. Product Portfolio
9.14. Manipal Fertility Hospital
9.14.1. Company Overview
9.14.2. Company Snapshot
9.14.3. Operating Business Segments
9.14.4. Product Portfolio
9.15. Cloudnine Hospitals
9.15.1. Company Overview
9.15.2. Company Snapshot
9.15.3. Operating Business Segments
9.15.4. Key Strategic Moves And Developments
9.15.5. Product Portfolio
*Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bloom Fertility Cente
  • Bourn Hall Clinic
  • Lab IVF Asia Pte. Ltd.
  • LG Life Sciences
  • Nova IVI Fertility
According to the report titled, ' India In Vitro Fertilization (IVF) Services Market by Gender, Procedure, Cycle Type, End User and Offerings: Opportunity Analysis and Industry Forecast, 2019-2026 ', The India IVF services market Size was valued at $478.2 million in 2018 and is estimated to reach $1,453.0 million by 2026, registering a CAGR of 14.7% during the analysis period.

In vitro fertilization (IVF) is the fertilization process of a woman's egg and a man's sperm, in this process mature eggs are collected (retrieved) from ovaries and fertilized by sperm in a laboratory. Then the fertilized egg is transferred to a uterus. This treatment is for women with the infertility or genetic problems. This technique is used to help a woman become pregnant. Fertilization process means the sperm has attached to and go in the egg. In vitro fertilization (IVF) is a form of an assisted reproductive technology (ART).

The major factor that boost the growth of the India in vitro fertilization services market are such as increase in the infertility rates caused due to surge in stress levels, surge in incidence of fertility-related diseases and changes in lifestyle. Further, emerging trend of delayed pregnancies among women, and increase in occurrences of gamete donations boosts the market. However, low awareness toward this technique in the society are certain factors which hinders the growth of the India IVF services market. Moreover, rise in the prevalence due to increase in risk factors, such as obesity, stress, polycystic ovarian syndrome (PCOS), sexually transmitted infections, endometrial tuberculosis, and other medical conditions, is expected to offer lucrative opportunities for market growth during the forecast period.

The India IVF services market is segmented based on gender, procedure, cycle type, offering and end user. Based on gender, it is divided into female infertility, male infertility, and both (combined) infertility. Based on procedure, it is classified into intracytoplasmic sperm injection (ICSI-IVF), non-ICSI-IVF, and intrauterine insemination (IUI). Based on cycle type, the market is categorized into fresh cycle (non-donor), thawed cycle (non-donor), and donor egg IVF cycle. Based on offering segment is divided into IVF drugs, IVF media and reagents and IVF and IUI services. Based on end user, it is segmented into fertility clinics, hospitals, surgical centers, and clinical research institutes.

Based on gender, the India in vitro fertilization services market is divided into female fertility, male fertility and other. The female fertility acquired the largest India IVF services market share in 2018 owing to rise in prevalence of female fertility related diseases such as ovulation disorders endometriosis, polycystic ovarian syndrome, problems associated with the cervix and damage associated with fallopian tubes, uterus. Furthermore, male fertility is expected to grow with fastest rate during the forecast period owing to the increase in awareness regarding male infertility.

Based on procedures, the India IVF services market is divided into ICSI IVF, Non-ICSI IVF and IUI. The ICSI IVF acquired the largest India IVF services market share in 2018. Furthermore, ICSI IVF is expected to grow with fastest rate during the forecast period owing to their applicability and utility with respect to IVF procedures.

Based on cycle type, the India IVF services market is divided into fresh cycle (non-donor), thawed cycle (non-donor) and donor egg IVF cycle. The fresh cycle (non-donor) acquired the largest India IVF services market share in 2018 due to increase in outcome of fresh cycle. In addition, thawed cycle (non-donor) is expected to grow with fastest rate during the forecast period owing to increase in aware about thawed cycle amongst the population.

Based on end user, the fertility clinics in the end user segment generated the highest revenue in 2018. The fertility clinics segment is the largest and the fastest segment during the forecast period owing to presence of large number of fertility clinics and availability and accessibility of different services related to IVF such as infertility treatment, IVF programs, egg donation, sperm donation, intracytoplasmic sperm injection (ICSI), intra-cytoplasmic morphologically selected sperm injection (IMSI), and others. Further, fertility clinics are expected to grow with fastest rate during the forecast period.

Key Findings of the India IVF Services Market:
By gender, female fertility in India in vitro fertilization services market accounted for largest share in 2018.
By procedures, ICSI IVF in India IVF services market accounted for largest share in 2018.
By cycle type, fresh IVF cycles in India in vitro fertilization services market accounted for largest share in 2018.
By end user, fertility clinics segment in India IVF services market accounted for largest market share in 2018.
By offering, IVF and IUI Services in India in vitro fertilization services market accounted for largest market share in 2018.
Note: Product cover images may vary from those shown
  • Sun Pharmaceuticals Industries Ltd.
  • Lab IVF Asia Pte. Ltd.
  • LG Life Sciences
  • Cadila Pharmaceuticals Ltd.
  • Bourn Hall Clinic
  • Morpheus Life Sciences Pvt. Ltd.
  • Southend Fertility and IVF Centre
  • Nova IVI Fertility
  • Bloom Fertility Cente
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...